Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
giulio.olivieri@uniroma1.it
Giulio Olivieri
Specializzando
Struttura:
Non assegnato
E-mail:
giulio.olivieri@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients
IMMUNOLOGY LETTERS
2024
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab
LUPUS
2023
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity
JOURNAL OF IMMUNOLOGY RESEARCH
2023
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon
AUTOIMMUNITY REVIEWS
2023
Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study
LIFE
2023
Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study
BIOMOLECULES
2022
Fever in systemic lupus erythematosus: associated clinical features and genetic factors
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022
The Impacts of the Clinical and Genetic Factors on Chronic Damage in Caucasian Systemic Lupus Erythematosus Patients
JOURNAL OF CLINICAL MEDICINE
2022
Erosive arthritis in systemic lupus erythematosus: application of cluster analysis
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022
Science and visual arts: binomial or dichotomy. a pilot study in systemic lupus erythematosus patients
LUPUS
2022
Can machine learning models support physicians in systemic lupus erythematosus diagnosis. results from a monocentric cohort
JOINT BONE SPINE
2022
Genetic diversity of staphylococcus aureus influences disease phenotype of systemic lupus erythematosus
RHEUMATOLOGY
2021
Immune checkpoint inhibitors and pre-existing antinuclear antibodies: the rheumatologist point of view
CLINICAL & TRANSLATIONAL ONCOLOGY
2021
Comprehensive disease control in systemic lupus erythematosus
SEMINARS IN ARTHRITIS AND RHEUMATISM
2021
Systemic lupus erythematosus before and after COVID-19 Lockdown. how the perception of disease changes through the lenses of narrative medicine
HEALTHCARE
2021
SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus. description of a case
LUPUS
2021
Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus. comparison between renal and non-renal involvement
JOINT BONE SPINE
2021
Erosive arthritis in systemic lupus erythematosus: not only Rhupus
LUPUS
2021
Joint involvement influences quality of life in systemic lupus erythematosus patients
LUPUS
2020
OP0204 LUPUS COMPREHENSIVE DISEASE CONTROL IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: APPLICATION OF A NEW INDEX
Annals of the Rheumatic DiseasesANNALS OF THE RHEUMATIC DISEASES
2020
1
2
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma